2025. Safety and Efficacy of Risankizumab in the Treatment of Chronic Plaque-Type Psoriasis: A Pilot Single-Arm, Single-Center, Prospective Cohort Study. Bangladesh Armed Forces Medical Journal. 58, 1 (Nov. 2025), 22–29. DOI:https://doi.org/10.3329/bafmj.v58i1.84958.